Kawagishimachi, Chuo-Ku
Niigata 951-8566
Japan
Niigata Cancer Center Hospital
lung cancer, EGFR, T790-negative, Osimertinib, Patient-initiated clinical trial
Lung cancer, MET, acquired resistance, cabozantinib, clinical trial
high-grade neuroendocrine carcinoma, Small-cell lung cancer, large-cell neuroendocrine carcinoma, cisplatin, irinotecan, etoposide, Relative dose intensity